No Record Found
sector: Pharmaceuticals
as on 6/13/2016 12:00:00 AM
₹ 4.65 -0.20 -4.12No Record Found
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
Demat Account
Trading Account
PROMOTER - TOTAL3.58%
Indian: 3.58%
Foreign: 0%
NON-PROMOTER - TOTAL 96.42%
Institutions: 0.02%
Non-Institutions: 96.41%
CUSTODIES - 0.00%
Custodies: 0.00%
Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Revenue | 962.68 | 706.12 | 467.73 | 362.55 |
yoy growth (%) | 36.34 | 50.97 | 29.01 | -- |
Raw materials | (722.04) | (527.37) | (369.61) | (305.07) |
As % of sales | 75.00 | 74.69 | 79.02 | 84.15 |
Employee costs | (20.31) | (15.65) | (10.61) | (6.65) |
As % of sales | 2.11 | 2.22 | 2.27 | 1.83 |
Other costs | (38.97) | (22.60) | (15.01) | (9.58) |
As % of sales | 4.05 | 3.20 | 3.21 | 2.64 |
Operating profit | 181.37 | 140.50 | 72.49 | 41.25 |
OPM | 18.84 | 19.90 | 15.50 | 11.38 |
Depreciation | (14.34) | (12.98) | (3.84) | (2.43) |
Interest expense | (78.51) | (60.30) | (28.96) | (16.39) |
Other income | 0.54 | 0.78 | 0.57 | 0.34 |
Profit before tax | 89.05 | 68.00 | 40.27 | 22.77 |
Taxes | (28.69) | (23.04) | (18.57) | (5.87) |
Tax rate | (32.22) | (33.88) | (46.11) | (25.77) |
Minorities and other | (1.87) | (1.57) | (0.83) | -- |
Adj. profit | 58.49 | 43.39 | 20.87 | 16.90 |
Exceptional items | -- | -- | -- | -- |
Net profit | 58.49 | 43.39 | 20.87 | 16.90 |
yoy growth (%) | 34.81 | 107.88 | 23.47 | -- |
NPM | 6.08 | 6.14 | 4.46 | 4.66 |
Y/e 31 Mar ( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Equity capital | 68.13 | 64.39 | 48.23 | 48.23 |
Preference capital | -- | -- | -- | -- |
Reserves | 214.92 | 133.84 | 96.06 | 73.38 |
Net worth | 283.05 | 198.23 | 144.29 | 121.61 |
Minority interest | 4.85 | 2.98 | 1.41 | -- |
Debt | 640.97 | 528.95 | 371.10 | 187.14 |
Deferred tax liabilities (net) | 41.79 | 32.30 | 22.84 | 11.92 |
Total liabilities | 970.66 | 762.46 | 539.64 | 320.67 |
Fixed assets | 423.27 | 295.05 | 297.92 | 63.56 |
Intangible assets | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Deferred tax asset (net) | 0.72 | 0.57 | 0.37 | 0.29 |
Net working capital | 540.88 | 442.58 | 218.71 | 236.03 |
Inventories | 199.64 | 125.05 | 89.40 | 57.11 |
Inventory Days | 75.69 | 64.64 | 69.77 | 57.49 |
Sundry debtors | 350.34 | 258.74 | 187.49 | 134.54 |
Debtor days | 132.83 | 133.75 | 146.31 | 135.45 |
Other current assets | 144.32 | 163.48 | 30.28 | 93.92 |
Sundry creditors | (95.98) | (68.13) | (39.72) | (40.82) |
Creditor days | 36.39 | 35.22 | 31.00 | 41.09 |
Other current liabilities | (57.44) | (36.56) | (48.74) | (8.72) |
Cash | 5.79 | 24.27 | 22.64 | 20.79 |
Total assets | 970.66 | 762.47 | 539.64 | 320.67 |
Y/e 31 Mar ( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Profit before tax | 89.05 | 68.00 | 40.27 | 22.77 |
Depreciation | (14.34) | (12.98) | (3.84) | (2.43) |
Tax paid | (28.69) | (23.04) | (18.57) | (5.87) |
Working capital 27,893 | 356.69 | 120.32 | (120.32) | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | 402.71 | 152.30 | (102.46) | -- |
Capital expenditure | 342.91 | 20.37 | (20.37) | -- |
Free cash flow | 745.62 | 172.67 | (122.83) | -- |
Equity raised | 255.16 | 207.49 | 228.57 | -- |
Investments | -- | -- | -- | -- |
Debt financing/disposal | 454.43 | 165.87 | (155.81) | -- |
Dividends paid | 5.45 | 4.82 | 3.38 | 2.19 |
Net in cash | 1460.66 | 550.86 | (46.69) | -- |
Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.335 | 50.967 | 29.009 | |
Op profit growth | 29.089 | 93.809 | 75.755 | |
EBIT growth | 30.607 | 85.323 | 76.779 | |
Net profit growth | 34.811 | 107.884 | 23.474 | |
Profitability ratios (%) | ||||
OPM | 18.839 | 19.897 | 15.499 | 11.377 |
EBIT margin | 17.406 | 18.169 | 14.801 | 10.801 |
Net profit margin | 6.076 | 6.144 | 4.462 | 4.662 |
RoCE | 19.337 | 19.706 | 16.094 | |
RoNW | 6.076 | 6.333 | 3.925 | |
RoA | 1.687 | 1.666 | 1.213 | |
Per share ratios (₹) | ||||
EPS | 8.72 | 9.16 | 0.44 | 0.34 |
Dividend per share | 0.8 | 1 | 0.07 | 0.07 |
Cash EPS | 6.48 | 6.304 | 0.353 | 0.3 |
Book value per share | 19.337 | 19.706 | 16.094 | |
Valuation ratios | ||||
P/E | 5 | 3.324 | 52.273 | 69.118 |
P/CEPS | 6.728 | 4.83 | 65.137 | 78.297 |
P/B | 1.05 | 0.741 | 7.689 | 9.32 |
EV/EBIDTA | 5.125 | 4.612 | 6.287 | 6.725 |
Payout (%) | ||||
Dividend payout | 10.908 | 12.907 | 18.83 | 15.027 |
Tax payout | -32.216 | -33.877 | -46.114 | -25.772 |
Liquidity ratios | ||||
Debtor days | 115.466 | 115.331 | 125.651 | |
Inventory days | 61.553 | 55.426 | 57.166 | |
Creditor days | -38.333 | -34.798 | -37.189 | |
Leverage ratios | ||||
Interest coverage | -2.134 | -2.128 | -2.39 | -2.389 |
Net debt / equity | 2.244 | 2.546 | 2.415 | 1.368 |
Net debt / op. profit | 3.502 | 3.592 | 4.807 | 4.033 |
Cost breakup (₹) | ||||
Material costs | -75.003 | -74.686 | -79.023 | -84.146 |
Employee costs | -2.11 | -2.216 | -2.269 | -1.835 |
Other costs | -4.048 | -3.201 | -3.21 | -2.643 |
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 1,515.15 | 88.24 | 3,63,535.24 | 721.31 | 0.76 | 4,903.66 | 100.23 |
Cipla Ltd | 1,387.90 | 34.08 | 1,12,058.35 | 1,114.14 | 0.61 | 3,798.31 | 320.56 |
Dr Reddys Laboratories Ltd | 6,259.15 | 26.24 | 1,04,414.05 | 475.20 | 0.64 | 4,083.10 | 1,361.85 |
Divis Laboratories Ltd | 3,911.75 | 76.13 | 1,03,844.67 | 358.00 | 0.77 | 1,808.00 | 474.52 |
Zydus Lifesciences Ltd | 980.65 | 36.71 | 98,676.34 | 450.40 | 0.62 | 2,225.10 | 145.11 |
Promoted by Arvind Kumar Shah, C M K Reddy, Chhotalal and Chandra Ravindran Arvind Remedies (ARL) was incorporated in Jun.88 as a private limited company which was later converted into a public limited company in Apr.95.ARL is engaged mainly formulation of Capsules and tablets. It manufactures over 80 products in various segments like ethical, generic and exports, besides institutions in the south. In 1999-2000, the company built up its own manufacturing facility at an expanded capacity of Tablets, Capsules, Liquids, Orals, Ointments, Ayurvedic preparations at Kakkalur, Thiruvallur Dist. under the state-of-the-art technology which is fully operational.In Nov.00, the company came out with a offering to existing shareholders through a rights issue of 14,86,000 equity shares of Rs 10 each at a premium of Rs 90 per share in the ratio of one equity share held for every four shares held.The company entered into an agreement into Bal Pharma Ltd Bangalore for manufacturing products of Bal Pharma Ltd. The company has decided to have a centralised distribution centre, for which it it going use already allotted 3 acres plot,which was allotted by SIDCO. The plans have been drawn to start the civil works and the proposed construction activities are scheduled to be completed in... Read More
Reports by
Reports by
No Record Found
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.